These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24717837)

  • 1. Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty.
    Wang Z; Anderson FA; Ward M; Bhattacharyya T
    PLoS One; 2014; 9(4):e91755. PubMed ID: 24717837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
    Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
    JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
    Chu JN; Maselli J; Auerbach AD; Fang MC
    Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
    Hovik O; Amlie EJ; Jenssen KK
    J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
    Richardson SS; Schairer WW; Sculco PK; Bostrom MP
    Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in Revision Total Joint Arthroplasty: A Retrospective Review of 1917 Cases.
    Manista GC; Batko BD; Sexton AC; Edmiston TA; Courtney PM; Hannon CP; Levine BR
    Orthopedics; 2019 Nov; 42(6):323-329. PubMed ID: 31505013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
    Runner RP; Shau DN; Staley CA; Roberson JR
    J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.